We report our case and review the literature on reversal DWI lesions, ADC thresholds and correlation between DWI lesion and outcome measured with clinical scales. A 30-years-old woman was admitted to our hospital 18 hours after stroke onset. Considering the absence of alterations on CT and the worsening of symptomatology, the patient underwent MRI, which showed a slightly hyperintense signal in FLAIR images in the left portion of the pons and midbrain and a more evident bilateral DWI hyperintensity of the pons. The patient was treated with mechanical and pharmacological intra-arterial thrombolysis. The patient showed a rapid improvement of symptoms. Two weeks after the treatment her clinical conditions were characterized by a residual right hemiparesis and complete recovery of right motility, respiratory and swallowing difficulties. MR examination demonstrated a slight signal alteration of the pons left hemiportion and a disappearance of the mesencephalic signal alteration and of the right portion of the pons. DWI lesions represent irreversibly damaged tissue but new evidence suggests that DWI lesions may be reversible, especially with reperfusion, by now well demonstrated in animal models. Therefore acute DWI lesions probably contain not only irreversibly injured tissue but also parts of the penumbra. The debate on the capability of ADC maps to discriminate irreversibly from reversibly damaged tissue is a matter of controversy. ADC values in human stoke are not an independent indicator of tissue viability. The use of thresholds may improve reproducibility but not validity.
KubikCSAdamsRD. Occlusion of the basilar artery: a clinical and pathological study. Brain. 1946; 59: 73–121.
2.
BiemondA. Thrombosis of the basilar artery and the vascularization of the brainstem. Brain. 1951; 74: 300–317.
3.
SiekertRGMillikanCH. Studies in cerebrovascular disease: II. Some clinical aspects of thrombosis of the basilar artery. Proc Mayo Clin. 1955; 30: 93–100.
4.
CraviotoHRey-BelletProsePH. Occlusion of the basilar artery: a clinical and pathologic study of 14 autopsied cases. Neurology. 1958; 8: 145–152.
LindsbergPJSoinneLTatlisumakT. (2004) Long-term outcome after intravenous thrombolysis of basilar artery occlusion. J Am Med Assoc. 292: 1862–1866.
10.
SchulteG.. (2006) Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. Am J Neuroradiol27: 2042–47.
11.
HackeWZeumerHFerbertA.. (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke19: 1216–1222.
12.
ZeumerHFreitagHJZanellaF. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase vs recombinant tissue plasminogen activator (rt-PA). Neuroradiology. 1993; 35: 159–162.
13.
MitchellPJGerratyRPDonnanGA. Thrombolysis in the vertebrobasilar circulation: the 402 Australian Urokinase Stroke Trial. Cerebrovasc Dis.1997; 7: 94–99.
14.
CrossDT3rdMoranCJAkinsPT. Collateral circulation and outcome after basilar artery thrombolysis. Am J Neuroradiol. 1998; 19: 1557–1563.
15.
BrandtTPessinMSKwanES. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke. 1996; 27: 875–881.
16.
OrlandiGMoscatoGPadolecchiaR. Early thrombolysis in stroke due to basilar artery occlusion. Neurol Sci.2001; 22: 399–402.
17.
EckertBKucinskiTPfeifferG. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis.2002; 14: 42–50.
18.
LevyEIFirlikADWisniewskiS. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery. 1999; 45: 539–548.
19.
SliwkaUMullMStelzerA. Long-term follow-up of patients after intraarterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc Dis.2001; 12: 214–219.
20.
EckertBKochCThomallaG. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTN stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST) - results of a multicenter study. Stroke. 2005; 36: 1160–1165.
21.
LindsbergPJMattleHP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006; 37: 922–928.
22.
MullerRPfefferkornTVatankhahB. Admission facility is associated with outcome of basilar artery occlusion. Stroke. 2007; 38: 1380–1383.
23.
ArnoldMNedeltchevKSchrothG. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry. 2004; 75:857–862.
24.
ChoT-HNighoghossianNTahonF. Brainstem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion. Am J Neuradiol. 2009, 30: 194–198.
25.
IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004; 35: 904–911.
26.
Flint AC Duckwiler GR Budzik RF et al. for the MERCI and Multi MERCI Writing Committee. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke. 2007; 38: 1274–1280.
27.
WijdicksEFNicholsDAThielenKR. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc. 1997; 72: 1005–1013.
28.
CrossDTMoranCJAkinsPT. Relationship between clot location and outcome after basilar artery thrombolysis. Am J Neuradiol. 1997; 18: 1221–1228.
29.
SchellingerPDJansenOFiebachJB. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol. 2001; 49: 460–469.
30.
EzakiYTsutsumiKOnizukaM. Retrospective analysis of neurological outcome after intra-arterial thrombolysis in basilar artery occlusion. Surg Neurol. 2003; 60: 423–430.
31.
WardlawJM. Surrogate outcomes: a cautionary note. Stroke. 2009; 40: 1029–1031.
32.
DavisSMDonnanGAParsonsMW. EPITHET investigators. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7: 299–309.
33.
RiversCSWardlawJMArmitagePA. Acute ischemic stroke lesion measurement on diffusion-weighted imaging-important considerations in designing acute stroke trials with magnetic resonance imaging. J Stroke Cerebrovasc Dis.2007; 16: 64–70.
34.
RhaJSaverJL. The impact of recanalization on ischemic stroke outcome. A meta-analysis. Stroke. 2007; 38: 967–973.
35.
WardlawJMMurrayVSandercockPAG. Thrombolysis for acute ischaemic stroke. An update of the Cochrane thrombolysis meta-analysis. Int J Stroke. 2008; 3 (suppl 1): 50.
36.
ArenillasJFRoviraAMolinaCA. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke. 2002; 33: 2197–2205.
37.
FurlanAHigashidaRWechslerL. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial-Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc. 1999; 282: 2003–2011.
38.
du Mesnil de RochemontRNeumann-HaefelinTBerkefeldJ. Magnetic resonance imaging in basilar artery occlusion. Arch Neurol. 2002; 59: 398–402.
BeckerKJPurcellLLHackeW. Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics. Crit Care Med.1996; 24:1729–1742.
41.
Von KummerR.. (2000) The effect of early and late brain tissue reperfusion on infarct volume. Stroke31:275.
42.
SchellingerP. (2000) Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke31: 1318–1328.
43.
StapfCMarshallRSMohrJP. Late intra-arterial thrombolysis. Eur J Med Res.2000; 5: 303–306.
44.
van EverdingenKJvan der GrondJKappelleLJ. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke. 1998; 29: 1783–1790.
45.
WarachS. Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI. Ann Neurol. 2002; 51: 11–13.
46.
KluytmansMvan EverdingenKJKappelleLJ. Prognostic value of perfusion- and diffusion-weighted MR imaging in first 3 days of stroke. Eur Radiol. 2000; 10: 1434–1441.
47.
LeeDHKangD-WAhnJS. Imaging of the ischemic penumbra in acute stroke. Korean J Radiol. 2005; 6: 64–74.
48.
BeauchampNJJrUlugAMPasseTJ. MR diffusion imaging in stroke: review and controversies. Radiographics. 1998; 18: 1269–1283.
49.
BairdAEBenfieldASchlaugG. Enlargement of human cerebral ischemic lesion volumes measured by diffusionweighted magnetic resonance imaging. Ann Neurol. 1997; 41: 581–589.
50.
LiFSilvaMDLiuTK-F. Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol. 2000; 48: 236–244.
51.
KidwellCSSaverJLMattielloJ. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47: 462–469.
52.
GrantPEHeJHalpernEF. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology. 2001; 221: 43–50.
53.
HussainMSBhagatYALiuS. DWI lesion volume reduction following acute stroke treatment with transient partial aortic obstruction. J Neuroimaging. 2010; 20: 379–381.
54.
MarksMPTongDCBeaulieuC. Evaluation of early reperfusion and IV tPA therapy using diffusion and perfusion-weighted MRI. Neurology. 1999; 52: 1792–1798.
55.
LansbergMGTongDNorbashA. Intra-arterial rtPA treatment of stroke assessed by diffusion- and perfusion-weighted MRI. Stroke. 1999; 30: 678–680.
56.
JansenOSchellingerPFiebachJ. Early recanalization in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet. 1999; 353: 2036–2037.
57.
TalebMLövbladKOEl-KoussyM. Reperfusion demonstrated by apparent diffusion coefficient mapping after local intra-arterial thrombolysis for ischaemic stroke. Neuroradiology. 2001; 43: 591–594.
58.
ParsonMBarberPAChalkJ. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002; 51: 28–37.
59.
FiehlerJ. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002; 33: 79–86.
60.
BarberPADarbyDGDesmondPM. Prediction of stroke outcome with echoplanar perfusion- and diffusion weighted MRI. Neurology. 1998; 51: 418–426.
61.
ThijsVNLansbergMGBeaulieuC. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multi-variable analysis. Stroke. 2000; 31: 2597–2602.
62.
BairdAEDambrosiaJJanketS. A Three-item scale for the early prediction of stroke recovery. Lancet. 2001; 357: 2095–2099.
63.
FiehlerJ. ADC and metabolites in stroke: even more confusion about diffusion?Stroke. 2003; 34: 87–88.
64.
EngelterSTProvenzaleJMPetrellaJR. Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. Cerebrovasc Dis.2003; 15: 188–191.
65.
HandP. J., Wardlaw JM, Rivers CS, et al. MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology. 2006; 66: 1159–1163.
66.
WardlawJMKeirSLBastinME. Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke?Neurology. 2002; 59: 1381–1387.
67.
LovbladKOBairdAESchlaugG. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997; 42: 164–170.
68.
OppenheimCSamsonYManaïR. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke. 2000; 31: 2175–2181.
69.
WarachSDasheJFEdelmanRR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996; 16: 53–59.
70.
EngelterSTWetzelSGRadueEW. The clinical significance of diffusion-weighted MR imaging in infratentorial strokes. Neurology. 2004; 62: 574–580.
71.
LinfanteILlinasRHSchlaugG. Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior circulation stroke. Arch Neurol. 2001; 58: 621–628.
72.
SatoSToyodaKUeharaT. Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology. 2008; 70: 2371–2377.
73.
KasnerSE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006; 5: 603–612.
74.
LibmanRBKwiatkowskiTGHansenMD. Differences between anterior and posterior circulation stroke in TOAST. Cerebrovasc Dis.2001; 11: 311–316.
75.
AdamsHPDavisPHLeiraEC. Baseline NIH Stroke Scale score strongly predicts outcome after stroke. A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 2003; 53: 126–135.
76.
ArnoldMNedeltchevKRemondaL. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psych. 2005; 76: 1373–1376.
77.
UedaTSakakiSKumonY. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999; 30: 2360–2365.
78.
ArnoldMSchrothGNedeltchevK. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002; 33: 1828–1833.
79.
Neumann-HaefelinTdu Mesnil de RochemontRFiebachJB. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke. 2004; 35: 109–114.
80.
PialatJBWiartMNighoghossianN. Evolution of lesion volume in acute stroke treated by intravenous t-PA. Magn Reson Imag. 2005; 22: 23–28.
81.
KnightRADereskiMOHelpernJA. Magnetic resonance imaging assessment of evolving focal cerebral ischemia:comparison with histopatology in rats. Stroke. 1994; 25: 1252–1261.
82.
LiuKLiFTatlisumakT. Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke. 2001; 32: 1897–1905.
83.
Johnston KC Wagner DP Wang X-Q et al. for the GAIN, Citicoline, and ASAP Investigators. Validation of an acute ischemic stroke model. Does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome?Stroke. 2007; 38: 1820–1825.
84.
NaDGThijsVNAlbersGW. Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. Am J Neuradiol. 2004; 25: 1331–1336.
85.
DesmondPMLovellACRawlinsonAA. The value of apparent diffusion coefficient maps in early cerebral ischemia. Am J Neuradiol. 2001; 22: 1260–1267.
86.
SchaeferPWHassankhaniAPutmanC. Characterization and evolution of diffusion MR imaging abnormalities in stroke patients undergoing intra-arterial thrombolysis. Am J Neuradiol. 2004; 25: 951–957.
87.
GeijerBLindgrenABrockstedtS. Persistent high signal changes in diffusion weighted MRI in late stages of small cortical and lacunar ischemic stroke lesions. Neuroradiology. 2001; 43: 115–122.
88.
SchulzUBrileyDMeagherT. Abnormalities on diffusion weighted magnetic resonance imaging performed several weeks after a minor stroke or transient ischaemic attack. J. Neurol. Neurosurg. Psych. 2003; 74: 734–738.
89.
LansbergMGThijsaVNO'BrienMW. Evolution of apparent diffusion coefficient, diffusion weighted and T2 weighted signal intensity of acute stroke. Am J Neuroradiol. 2001; 22: 637–644.
90.
SchaeferPWOzsunaraYHeaJ. Assessing tissue viability with MR diffusion and perfusion imaging. Am J Neuradiol. 2003; 24: 436–443.
91.
DardzinskiBSotakCHFisherM. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med.1993; 30: 318–325.
92.
OlahLWeckerSHoehnM. Relation of apparent diffusion coefficient changes and metabolic disturbances after one hour of focal cerebral ischemia and at different reperfusion rates in rats. J Cereb Blood Flow Metab. 2001; 21: 430–439.
93.
Hoehn-BerlageMEisMBackT. Changes of relaxation times (T1, T2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution, regional extent and comparison with histology. Magn. Res. Med.1995; 34: 824–834.
94.
MinematsuKLiLSotakC. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging. Stroke. 1992; 23: 1304–1310.
95.
KidwellCSaverJLStarkmanS. Late secondary ischemic injury in patients receiving intra-arterial thrombolysis. Ann Neurol. 2002; 52: 698–703.
96.
LiFLiuKFSilvaMD. Transient and permanent resolution of ischemic lesions on diffusion weighted imaging after brief periods of focal ischemia in rats. Stroke. 2000; 31: 946–954.
97.
Neumann-HaefelinTKastrupAde CrespignyA. Serial MRI after transient focal cerebral ischemia in rats. Stroke. 2000; 31: 1652–1672.
98.
TanakaYKuroiwaTMiyasakaN. Recovery of apparent diffusion coefficient after embolic stroke does not signify complete salvage of post-ischemic neuronal tissue. Acta Neurochir Suppl. 2003; 86: 141–145.
99.
RingerTNeumann-HaefelinTSobelRA. Reversal of early diffusion-weighted magnetic resonance imaging abnormalities does not necessarily reflect tissue salvage in experimental cerebral ischemia. Stroke. 2001; 32; 2362–2369.
100.
LiFHanSSTatlisumakT. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol. 1999; 46: 333–342.
101.
van Lookeren CampagneMThomasGRThibodeaux. Secondary reduction in the apparent diffusion coefficient of water, increase in cerebral blood volume, and delayed neuronal death after middle cerebral artery occlusion and early reperfusion in the rat. J Cereb Blood Flow Metab. 1999; 19: 1354–1364.
